Latest Insider Transactions at Neumora Therapeutics, Inc. (NMRA)
This section provides a real-time view of insider transactions for Neumora Therapeutics, Inc. (NMRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Neumora Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Neumora Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2024
|
Paul L Berns |
SELL
Bona fide gift
|
Direct |
399,291
-1.73%
|
-
|
|
Oct 18
2024
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
14,049
-41.14%
|
$238,833
$17.03 P/Share
|
|
Oct 18
2024
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
14,049
+18.88%
|
$70,245
$5.66 P/Share
|
|
Oct 17
2024
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
7,739
-27.8%
|
$131,563
$17.01 P/Share
|
|
Oct 17
2024
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
7,739
+9.14%
|
$46,434
$6.54 P/Share
|
|
Oct 10
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
8,260
-2.56%
|
$123,900
$15.09 P/Share
|
|
Oct 09
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
5,563
-1.69%
|
$83,445
$15.01 P/Share
|
|
Sep 18
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
10,676
-3.15%
|
$128,112
$12.09 P/Share
|
|
Sep 17
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
30,788
-8.32%
|
$338,668
$11.81 P/Share
|
|
Sep 12
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
32,948
-8.18%
|
$362,428
$11.43 P/Share
|
|
Aug 27
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
15,693
-10.15%
|
$172,623
$11.39 P/Share
|
|
Aug 26
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
31,642
-16.98%
|
$348,062
$11.78 P/Share
|
|
Aug 23
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,169
-11.48%
|
$265,859
$11.59 P/Share
|
|
Aug 22
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
28,496
-11.92%
|
$313,456
$11.63 P/Share
|
|
Jun 13
2024
|
Alaa Halawa |
BUY
Grant, award, or other acquisition
|
Direct |
20,100
+50.0%
|
-
|
|
Jun 13
2024
|
David Piacquad |
BUY
Grant, award, or other acquisition
|
Direct |
20,100
+50.0%
|
-
|
|
Jun 13
2024
|
Maykin Ho |
BUY
Grant, award, or other acquisition
|
Direct |
20,100
+50.0%
|
-
|
|
Jun 13
2024
|
Kristina Burow |
BUY
Grant, award, or other acquisition
|
Direct |
20,100
+29.64%
|
-
|
|
Jun 13
2024
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
20,100
+50.0%
|
-
|
|
Apr 22
2024
|
Daljit Singh Aurora Chief Strategy Officer |
SELL
Bona fide gift
|
Direct |
114,703
-54.05%
|
-
|
|
Apr 17
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Bona fide gift
|
Indirect |
238,965
-50.0%
|
-
|
|
Feb 14
2024
|
Daljit Singh Aurora Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+31.48%
|
-
|
|
Feb 14
2024
|
Joshua Pinto Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+20.78%
|
-
|
|
Feb 14
2024
|
Henry O Gosebruch President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+14.75%
|
-
|
|
Feb 14
2024
|
Paul L Berns |
BUY
Grant, award, or other acquisition
|
Direct |
171,250
+2.14%
|
-
|
|
Feb 14
2024
|
Carol Y. Suh Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+18.49%
|
-
|
|
Feb 14
2024
|
Robert A. Lenz Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.04%
|
-
|
|
Feb 14
2024
|
Michael Lee Milligan |
BUY
Grant, award, or other acquisition
|
Direct |
20,625
+45.76%
|
-
|
|
Dec 08
2023
|
Kristina Burow |
BUY
Other acquisition or disposition
|
Direct |
13,997
+33.64%
|
-
|
|
Dec 08
2023
|
Kristina Burow |
BUY
Other acquisition or disposition
|
Indirect |
1,879,654
+27.9%
|
-
|
|
Dec 08
2023
|
Arch Venture Partners X, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,879,654
+33.63%
|
-
|
|
Dec 08
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,879,654
+33.63%
|
-
|
|
Nov 14
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
3,357
+0.08%
|
$36,927
$11.98 P/Share
|
|
Nov 14
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,357
+0.08%
|
$36,927
$11.98 P/Share
|
|
Nov 13
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
31,653
+0.76%
|
$348,183
$11.75 P/Share
|
|
Nov 13
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
31,653
+0.76%
|
$348,183
$11.75 P/Share
|
|
Nov 10
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,275
+0.21%
|
$190,025
$11.56 P/Share
|
|
Nov 10
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
17,275
+0.21%
|
$190,025
$11.56 P/Share
|
|
Nov 09
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
31,079
+0.76%
|
$310,790
$10.53 P/Share
|
|
Nov 09
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
31,079
+0.76%
|
$310,790
$10.53 P/Share
|
|
Nov 08
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
92,251
+1.13%
|
$1,014,761
$11.29 P/Share
|
|
Nov 08
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
92,251
+1.13%
|
$1,014,761
$11.29 P/Share
|
|
Nov 07
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,192
+0.76%
|
$332,112
$11.5 P/Share
|
|
Nov 07
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
30,192
+0.76%
|
$332,112
$11.5 P/Share
|
|
Nov 06
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
43,082
+1.09%
|
$473,902
$11.55 P/Share
|
|
Nov 06
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
43,082
+1.09%
|
$473,902
$11.55 P/Share
|
|
Nov 03
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,420
+0.57%
|
$246,620
$11.38 P/Share
|
|
Nov 03
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
22,420
+0.57%
|
$246,620
$11.38 P/Share
|
|
Sep 29
2023
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
34,560
+0.89%
|
$449,280
$13.98 P/Share
|
|
Sep 29
2023
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
34,560
+0.89%
|
$449,280
$13.98 P/Share
|